Allergan - 26 Year Stock Price History | AGN

Historical daily share price chart and data for Allergan since 1993 adjusted for splits. The latest closing stock price for Allergan as of April 22, 2019 is 140.26.
  • The all-time high Allergan stock price is 327.64, which is 133.6% above the current share price.
  • The Allergan 52-week high stock price is 191.60, which is 36.6% above the current share price.
  • The Allergan 52-week low stock price is 129.13, which is 7.9% below the current share price.
  • The average Allergan stock price for the last 52 weeks is 160.97.
Allergan Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 144.7730 135.1587 159.9365 131.3889 140.2600 5.50%
2018 166.6281 166.5240 191.5997 129.1309 132.9505 -16.87%
2017 213.4482 208.6368 248.6787 159.9342 159.9342 -21.09%
2016 233.2541 296.7276 297.9436 181.8853 202.6727 -32.80%
2015 286.8190 250.0765 327.6386 243.2922 301.5819 21.40%
2014 212.3537 162.1787 261.1555 162.0629 248.4166 53.22%
2013 118.6135 81.2129 162.1304 80.1424 162.1304 95.48%
2012 71.7680 58.4721 87.6166 53.9008 82.9392 42.53%
2011 60.1000 49.6574 69.5339 48.7895 58.1924 16.82%
2010 42.0648 38.8560 50.1010 36.3486 49.8117 30.40%
2009 31.3167 25.3640 38.6921 22.8951 38.2002 49.08%
2008 26.3231 25.9233 30.0317 20.0211 25.6243 -2.10%
2007 28.3763 25.3640 32.4909 24.3803 26.1741 4.26%
2006 26.0109 31.7676 33.5229 20.6576 25.1036 -19.93%
2005 30.9325 30.7646 35.3070 27.1095 31.3529 -0.91%
2004 33.5813 43.7263 47.3621 23.8209 31.6423 -28.67%
2003 35.8128 27.6400 47.0632 26.0583 44.3628 62.72%
2002 25.1997 29.9160 31.6423 17.9573 27.2638 -9.94%
2001 49.6420 46.5906 63.5063 26.8877 30.2728 -38.68%
2000 47.8993 33.7543 67.2386 32.6742 49.3681 42.95%
1999 38.6521 55.8779 57.0255 26.3380 34.5355 -43.05%
1998 43.0003 31.1601 60.6420 29.6556 60.6420 93.83%
1997 23.3556 21.5787 32.4283 15.7295 31.2854 44.37%
1996 18.9525 22.9336 23.7486 12.5373 21.6703 -8.29%
1995 17.5714 12.4168 23.8691 10.1263 23.6280 86.67%
1994 10.3807 11.3318 13.8634 6.2687 12.6579 3.96%
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $46.669B $15.787B
Allergan, Inc. is a healthcare company. It focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. Allergan plc, formerly known as Actavis plc, is headquartered in Dublin, Ireland.
Stock Name Country Market Cap PE Ratio
Teva Pharmaceutical Industries (TEVA) Israel $14.602B 5.04
Mylan (MYL) United Kingdom $13.853B 5.86
Bausch Health Cos (BHC) Canada $8.091B 5.75
Dr Reddy's Laboratories (RDY) India $6.770B 27.00
Supernus Pharmaceuticals (SUPN) United States $1.887B 17.51
Mallinckrodt Public Limited Company (MNK) United Kingdom $1.523B 2.47
Amphastar Pharmaceuticals (AMPH) United States $0.943B 87.65
Homology Medicines (FIXX) United States $0.832B 0.00
CymaBay Therapeutics (CBAY) United States $0.718B 0.00
Voyager Therapeutics (VYGR) United States $0.626B 0.00
Assembly Biosciences (ASMB) United States $0.423B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.410B 0.00
Akorn (AKRX) United States $0.348B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.172B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.170B 0.00
Sol-Gel Technologies (SLGL) Israel $0.132B 0.00
Acasti Pharma (ACST) Canada $0.074B 0.00
Aquinox Pharmaceuticals (AQXP) Canada $0.061B 0.00
Agile Therapeutics (AGRX) United States $0.060B 0.00
Teligent (TLGT) United States $0.044B 0.00
Aevi Genomic Medicine (GNMX) United States $0.014B 0.00
Evoke Pharma (EVOK) United States $0.013B 0.00